Regenxbio (RGNX) Change in Cash (2014 - 2025)

Regenxbio's Change in Cash history runs 12 years deep, the most recent figure standing at -$24.3 million for Q4 2025.

• In Q4 2025, Change in Cash fell 2777.23% year-over-year to -$24.3 million; the TTM figure through Dec 2025 stood at -$23.1 million (down 200.24% YoY), while the FY2025 annual figure was -$23.1 million, down 200.24% from the prior year.
• Change in Cash for Q4 2025 stood at -$24.3 million, down from -$20.8 million in the prior quarter.
• The five-year high for Change in Cash was $117.5 million in Q4 2021, with the low at -$153.3 million in Q1 2022.
• The 5-year median for Change in Cash is -$21.2 million (2022), against an average of -$15.2 million.
• The sharpest annual moves came in 2021 and 2024: Change in Cash plunged 45476.7% in 2021, then surged 392.07% in 2024.
• Regenxbio's Change in Cash stood at $117.5 million in 2021, then tumbled by 118.37% to -$21.6 million in 2022, then advanced by 13.17% to -$18.7 million in 2023, then jumped by 104.85% to $909000.0 in 2024, then slumped by 2777.23% to -$24.3 million in 2025.
• Business Quant data shows RGNX's Change in Cash at -$24.3 million in Q4 2025, -$20.8 million in Q3 2025, and -$50.5 million in Q2 2025.